Banning smoking in hospitals  by Turton, C.
714 Letters to the Editor 
check the smoking habits of any young adult who 
develops this condition. 
J. B. BUICK, R. C. LOWRY AND M. RILEY 
Respiratory Investigation Centre 
Belfast City Hospital, U.K. 
2 June 1995 
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Dear Editor 
Air filtration units 
We would like to thank Warner and Warner for 
their comments (1) on our paper entitled ‘Domicili- 
ary air filtration units .’ (2). We wholeheartedly 
agree with their views on the excessive technological 
claims which are being made with regard to the 
benefits of simplistic devices aimed at minimizing 
allergen exposure and subsequent therapeutic expec- 
tations. It is quite important that journals are also 
prepared to publish negative studies in this field, 
otherwise such approaches (air filters, dehumidi- 
fiers, ionisers and vacuum cleaners) could become 
an accepted part of asthma management, without 
scientific merit. 
However, we must contest their views with regard 
to air sampling and their explanation for the inability 
of our measurements to quantify airborne levels of 
dust mite. Previous reports from other centres have 
suggested that mite allergen can only be quantita- 
tively detected in the air after significant disturbance 
of the reservoir (carpets etc.). In addition, the com- 
mercially available assays have a lower limit of 
sensitivity of 5 ng ml - ’ Derp I when the linear part 
o&the standard curve is used for analysis (3). Use 
of the non-linear part of the standard curve is scien- 
tifically inappropriate and, at best, only semi- 
quantitative. 
The major determining factor in the low airborne 
levels of mite allergen is the large particle size and 
fast settling rate of- Der p I, compared to animal 
allergens for example, which have been repeatedly 
and reliably measured from airborne samples. 
Currently available mite assays do have satisfac- 
tory sensitivity to quantitatively measure levels of 
allergen in dust collected for reservoir samples 
(vacuumed carpets/mattresses etc.), but they remain 
insufficiently sensitive to measure airborne levels. In 
our paper, we tried to overcome this lack of sensitiv- 
ity by increasing the volume of air, and therefore 
sample load, without a corresponding increase in the 
diluent volume, thus increasing the concentration of 
allergen for assay by at least 15fold. Warner and 
Warner’s suggestion that using high volume samplers 
filters the air and therefore dilutes the sample com- 
pared to using lower flow samplers is unlikely to be 
relevant as, even with high flow samples, the volume 
of air sampled is only 10 m3 which is equivalent to 
less than one-quarter of a normal room volume. Any 
small effect of filtering this proportion of room air 
would be more than compensated for by the extra 
antigen load produced by a larger sample volume, on 
the filter and subsequently in the assay. 
We have also analysed the effect of sonication on 
samples which they have recommended. This study 
demonstrated no increase in analysed concentrations 
after sonication of the sample (4) which again is not 
surprising in view of the well demonstrated, rapid 
solubility of the mite allergen. 
Unfortunately the inability to reliably measure 
airborne Der p I will prevent satisfactory assessment 
of devices claimed to produce a reduction in the 
airborne mite allergen. It will be necessary to con- 
tinue to use reservoir sampling as the standard of 
assessment of exposure until more sensitive Derp I 
assays are available. 
C. J. WARBUTON, R. McL. NIVEN AND 
C. A. C. PICKERING 
North West Lung Centre 
Wythenshawe Hospital, Manchester, U.K. 
20 June 1995 
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Dear Editor 
Banning smoking in hospitals 
Many will sympathize with the motives behind Dr. 
Kayente’s call for a total ban on smoking in hospitals 
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(1). Unfortunately it is not that easy and policies, like 
laws, need to be seen to be just and enforcable. In 
Brighton, we spent 3 years working towards ‘Smoke 
Free’, the only exception being the discretion of 
senior clinicians to permit bereaved relatives or dis- 
tressed patients to smoke. There were consultation 
exercises; plans to help smoking staff, to train staff, to 
help and support patients, to produce literature and 
the inevitable media campaign. The action plan 
included 53 points but, despite very thorough prepa- 
ration, we never won the support of all staff. There is 
certainly very much less smoking than before and we 
have no designated smoking areas. Nevertheless, it is 
hard to find a practical solution in the Accident & 
Emergency Departments for the aggressive drunk 
who needs casualty attention, or caring solutions for 
the acutely bereaved relative or mentally disturbed 
deliberate self-harm patient. The stronger the policy, 
the stronger the positive health message, but anyone 
who thinks a total ban can be enforced needs to take 
off their blinkers. 
C. TURTON 
Brighton Health Care NHS Trust 
The Hove General Hospital, U.K. 
7 July 1995 
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